Frimley, UK, 2015-Feb-16
The Centre, a joint venture between Gloucestershire Hospitals NHS Foundation Trust and medical charity Cobalt Health, has found that the investment in the ultrasound technology has already significantly increased the speed and precision of biopsy procedures, with abnormal areas standing out more prominently from background breast tissue.
“The pace of advancements in ultrasound is incredibly rapid and as such the installation of these new systems from Siemens Healthcare enables us to take full advantage of the evolution of this technology,” states Professor Iain Lyburn, Clinical Director of Breast Screening at Gloucestershire Hospitals NHS Foundation Trust.
Professor Lyburn adds, “The ACUSON S2000 enhances our diagnostic confidence by enabling us to look at the breast in greater detail following mammograms. It also allows for further assessment to clarify abnormalities with ultrasound used for biopsies, with patients lying comfortably thanks to the ergonomic design. The elastography package is very useful for evaluating lesions and the hockey stick transducer enables a more thorough assessment of the axilla for lymph nodes.”
Cheltenham-based Thirlestaine Breast Centre, which sees patients from both GP referrals and mammogram recalls, has adapted quickly to using the technology, with staff providing positive feedback regarding the systems’ intuitive feel and interface. The ACUSON S2000s will also be used for wire-guided procedures for the identification of small cancer cells to assist with cancer removal, also helping to optimise the speed of this procedure.
The ACUSON S2000 delivers clear image resolution, helping fine tissue detail to be distinguished. The system, that features high-density transducers, is focused on maximum user comfort and flexibility – whether seated or standing, the natural and extended reach zones are designed for ease-of- use, with the frequently used controls conveniently located. eSieScan™ workflow protocols are also incorporated to help to streamline clinical workflow.
John Martin, Regional Sales Manager at Siemens Healthcare, states, “The strong feedback that we have received from Thirlestaine Breast Centre regarding its positive experience to date with using this new diagnostic ultrasound technology is very encouraging. As improvements in the identification of, and treatment for, breast cancer remains of key importance, we look forward to continuing to support the Centre’s delivery of high-quality screening, diagnosis and patient care.”
Siemens Healthcare is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimising clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 52,000 employees worldwide and operates around the world www.siemens.co.uk/healthcare.
-Ends-
Media contacts
Laura Bennett
Tel: 07808 823598
Email: laura.bennett@siemens.com
Holly Wale / Ben Veal
Tel: 01225 471202
Email: benv@mediasafari.co.uk
For further information, please see: www.siemens.co.uk/press
Follow us on Twitter at: www.twitter.com/siemensuknews
About Siemens
Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 165 years. The company is active in more than 200 countries, focusing on the areas of electrification, automation and digitalization. One of the world’s largest producers of energy-efficient, resource-saving technologies, Siemens is No. 1 in offshore wind turbine construction, a leading supplier of combined cycle turbines for power generation, a major provider of power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. The company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2014, which ended on September 30, 2014, Siemens generated revenue from continuing operations of €71.9 billion and net income of €5.5 billion. At the end of September 2014, the company had around 357,000 employees worldwide. Further information is available on the Internet at www.siemens.com.
